Komori

Matters Concerning Controlling Shareholders

株式会社スズケンが当社株式の20.3%を保有する「その他の関係会社」であることと、当社グループとの関係・取引内容を開示した。支配株主や親会社への変更を示す書類ではない。

Worth reading
78Important
Scored from 1 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
20.3
Voting rights ownership ratio (%)
Wording
Definitive
How definitive the wording is.

Governance structure

Controlling shareholder
株式会社スズケン20.30%Voting rights

その他の関係会社)、議決権所有割合20.3%(直接所有分20.3%、合算対象分-

When one company holds most of the voting rights, its wishes are more likely to prevail in management. How the interests of minority shareholders are protected is a key issue.

Changes this time

No changes from the previous report are described.

Governance structure
ItemDetails
Controlling shareholder株式会社スズケン(その他の関係会社)、議決権所有割合20.3%(直接所有分20.3%、合算対象分-)
Changes this timeNo changes from the previous report are described.
Items this document does not state (6)
Corporate Governance StructureNumber of directorsNumber of independent officersCommitteePolicy on cross-shareholdingsTakeover defenses

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

株式会社スズケンについて、支配株主等に関する事項を知らせるため。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Matters Concerning Controlling Shareholders | Pharmarise Holdings Corporation (2796) timely disclosure | Komori